The increasing demand for controlled immunological research and therapeutic development has spurred significant progress in recombinant cytokine generation. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique physiological roles, are frequently generated using various expression platforms, including microbial hosts, animal cell lines, and baculovi